Abstract
Tissue-resident memory T (TRM) cells positively correlate with cancer survival, but the anti-tumor mechanisms underlying this relationship are not understood. This review reconciles these observations, summarizing concepts of T cell immunosurveillance, fundamental TRM cell biology, and clinical observations on the role of TRM cells in cancer and immunotherapy outcomes. We also discuss emerging strategies that utilize TRM-phenotype cells for patient diagnostics, staging, and therapy. Current challenges are highlighted, including a lack of standardized T cell nomenclature and our limited understanding of relationships between T cell markers and underlying tumor biology. Existing findings are integrated into a summary of the field while emphasizing opportunities for future research.
Original language | English (US) |
---|---|
Pages (from-to) | 1734-1751 |
Number of pages | 18 |
Journal | Immunity |
Volume | 57 |
Issue number | 8 |
DOIs | |
State | Published - Aug 13 2024 |
Bibliographical note
Publisher Copyright:© 2024 Elsevier Inc.
PubMed: MeSH publication types
- Journal Article
- Review